$19.92
-0.07 (-0.35%)
Open$20.06
Previous Close$19.99
Day High$20.22
Day Low$18.62
52W High$42.14
52W Low$7.45
Volume—
Avg Volume559.1K
Market Cap19.50M
P/E Ratio—
EPS$-142.73
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 6.00M | 5.90M | 5.57M |
| Net Income | -817,172 | -706,875 | -767,435 |
| Profit Margin | -13.6% | -12.0% | -13.8% |
| EBITDA | -1,135,758 | -954,399 | -978,652 |
| Free Cash Flow | -597,971 | -436,320 | -559,358 |
| Rev Growth | +2.3% | +18.9% | +16.5% |
| Debt/Equity | 0.18 | 0.16 | 0.22 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |